Organization
Sanofi
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Sanofi
... begun investigations into the rollout of the immunisation program by French drugmaker Sanofi, which has come under fire for discounting early warnings that its vaccine ...
... As Sanofi looks to reshape itself and offload its European generics business, it's reportedly ...
... And Alnylam announced Monday that it would restructure its RNAi collaboration with Sanofi—now, the rights to patisiran and fitusiran are divided by asset rather than ...
... drug while working at TargeGen Inc., according to Impact's website. French drugmaker Sanofi acquired TargeGen in 2010 for an upfront payment of $75 million. Sanofi ...
... around $90 million in extra funding), all for JAK2 inhibitor fedratinib, a Sanofi castoff. This represents a whiplash turnaround for fedratinib, albeit one that was ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron to accelerate and expand investment ...
... patients in need. Further, with our recently completed strategic restructuring of our Sanofi alliance, we are now poised to optimize our ATTR amyloidosis programs, patisiran ...
... Alnylam Pharmaceuticals, Inc . (Nasdaq: ALNY), the leading RNAi therapeutics company, and Sanofi announced today a strategic restructuring of their RNAi therapeutics alliance to streamline ...
... on Sunday, January 7, 2018.The event will be presented in collaboration with Sanofi. The invitation-only event will feature two panel discussions looking at the importance ...
... Cambridge, Mass. - Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Alnylam submit Marketing Authorization Application to ...
... investigations into the rollout of the immunization program by the French drugmaker Sanofi, which has come under fire for discounting early warnings that its vaccine ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA lifts clinical hold on fitusiran - Clinical ...
... TARRYTOWN, N.Y. and PARIS - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive topline results from a pivotal Phase 2 clinical study ...
... PARIS, France - Sanofi will host an analyst meeting in Paris today to discuss the company's ...
... unmet need in advanced CSCC," said Elias Zerhouni, MD, President, Global R&D, Sanofi. "We look forward to working with regulatory agencies globally to bring this ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi presents R&D strategy and innovative pipeline -- ...
... Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce positive topline pivotal results ...
... It may be way back in the race for market share, but Sanofi and Regeneron touted new topline data for their midstage checkpoint inhibitor in ...
... --The U.S. Food and Drug Administration (FDA) has approved Sanofi's Admelog®, the first follow-on insulin lispro to help people living with diabetes ...
... CAMBRIDGE, Mass. - Sanofi has launched two new late-stage clinical studies to determine if an investigational ...
... A Sanofi executive defended the company's dengue vaccine before lawmakers in the Philippines Monday, ...
... Sanofi has launched two new late-stage clinical studies to determine if an investigational ...
... observational analysis of a large dataset of U.S. electronic health records by Sanofi and IBM Watson Health and was presented today at the International Diabetes ...
... the study will meet its primary objective is low. Based on this, Sanofi has therefore decided to discontinue clinical development of its experimental Clostridium difficile ...
Want to see the full history on Sanofi? Upgrade to RelSci Pro now!
Start My Free Trial